95 related articles for article (PubMed ID: 8556228)
1. Adjuvant therapy with 5-fluoro-1-(2-tetrahydrofuryl)-2,4 (1H,3H)-pyrimidinedione (UFT) and Bestatin in patients with transitional cell carcinoma of the bladder--comparison between UFT therapy alone and UFT therapy in combination with Bestatin.
Uchibayashi T; Kunimi K; Yamamoto H; Koshida K
Int J Clin Pharmacol Ther; 1995 Aug; 33(8):465-8. PubMed ID: 8556228
[TBL] [Abstract][Full Text] [Related]
2. [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
Uchida K; Takeshima H; Kikuchi K; Shimazui T; Miyanaga N; Kawai K; Akaza H; Tsuchiya A; Noguchi R; Hattori K; Manabe F; Matsuki K; Suzuki R; Ishikawa S; Kondo F; Kobayashi T; Koiso K
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1179-87. PubMed ID: 9679581
[TBL] [Abstract][Full Text] [Related]
3. [Prophylactic effect of UFT on the recurrence of bladder cancer].
Naito K; Hisazumi H; Saka A; Nakamura T; Kanda S; Mikawa I; Ejiri S; Miyagi T; Katsumi T; Kitagawa K
Hinyokika Kiyo; 1990 Apr; 36(4):487-94. PubMed ID: 2116083
[TBL] [Abstract][Full Text] [Related]
4. [Prophylactic effect of UFT in combination with intravesical chemotherapy on the recurrence of superficial bladder tumor].
Yoshida O; Kakehi Y; Nishio Y; Tomoyoshi T; Konami T; Usui T; Igawa M; Takenaka I; Fujita K
Hinyokika Kiyo; 1992 Dec; 38(12):1437-43. PubMed ID: 1288238
[TBL] [Abstract][Full Text] [Related]
5. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
6. [Hyperthermic treatment with peplomycin and bestatin in superficial bladder cancer].
Kitagawa M; Ushiyama T; Suzuki K; Tajima A; Aso Y
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1820-6. PubMed ID: 2412496
[TBL] [Abstract][Full Text] [Related]
7. [A comparative clinical trial of UFT treatment and intravesical adriamycin instillation to prevent recurrence of superficial bladder cancer].
Masuda F; Mori Y; Torii S; Kawashima Y; Kobari T; Hosobe T
Gan To Kagaku Ryoho; 1992 Apr; 19(4):505-8. PubMed ID: 1558400
[TBL] [Abstract][Full Text] [Related]
8. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
Hasegawa K; Takayama T; Ijichi M; Matsuyama Y; Imamura H; Sano K; Sugawara Y; Kokudo N; Makuuchi M
Hepatology; 2006 Oct; 44(4):891-5. PubMed ID: 17006925
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
10. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
[TBL] [Abstract][Full Text] [Related]
11. [Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma].
Nakagami Y; Lin TT; Ito H; Hirasawa S; Tannawa K; Fujioka Y; Ogawa H; Tanaka K; Yamada N; Ishii Y
Hinyokika Kiyo; 1987 Oct; 33(10):1728-32. PubMed ID: 3128071
[TBL] [Abstract][Full Text] [Related]
12. [Randomized controlled trial of postoperative adjuvant chemotherapy with bestatin for gastric cancer].
Tanaka T; Oka T; Hashimoto I
Gan To Kagaku Ryoho; 1985 Jan; 12(1):125-33. PubMed ID: 3917653
[TBL] [Abstract][Full Text] [Related]
13. [Successful inhibition of bladder tumor recurrence by oral administration of UFT].
Nakamoto T; Igawa M; Usui T
Gan To Kagaku Ryoho; 1994 Apr; 21(5):697-9. PubMed ID: 8154896
[No Abstract] [Full Text] [Related]
14. [Case report of a complete regression of para-aortic lymph node metastasis from bladder cancer by oral administration of UFT].
Nakano E; Iwasaki A; Seguchi T; Sugao H; Yoshioka T; Tada Y; Matsuda M; Sonoda T
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):415-7. PubMed ID: 2494950
[TBL] [Abstract][Full Text] [Related]
15. [Postoperative adjuvant immunochemotherapy with bestatin for stomach cancer. Randomized controlled trial: first report].
Yoshinaka K; Nakano A; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1458-64. PubMed ID: 3925887
[TBL] [Abstract][Full Text] [Related]
16. [Treatments for advanced transitional cell carcinoma of the urinary tract: chemotherapy and operation].
Ozono S; Takashima K; Tabata S; Hirao Y; Okajima E
Hinyokika Kiyo; 1994 Oct; 40(10):931-8. PubMed ID: 7992711
[TBL] [Abstract][Full Text] [Related]
17. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
[TBL] [Abstract][Full Text] [Related]
18. [Intravesial instillation of recombination interferon-alpha and pirarubicin in the prophylaxis of local recurrence after resection of the superficial bladder cancer].
Deng JH; Bai JL; Zhang SS; Ma PC; Wan JH
Ai Zheng; 2004 Jul; 23(7):839-41. PubMed ID: 15248924
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy with tegafur/uracil administration after transcatheter arterial chemoembolization for advanced hepatocellular carcinoma.
Ueda H; Tanaka H; Kida Y; Fukuchi H; Ichinose M
Oncol Rep; 2008 May; 19(5):1355-61. PubMed ID: 18425398
[TBL] [Abstract][Full Text] [Related]
20. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
Imaizumi M;
Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
